Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M V Matveeva

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Voprosy Kurortologii, Fizioterapii, I Lechebnoi Fizicheskoi Kultury|June 27, 2024
[Physical rehabilitation in sarcopenia: modern approaches. (A literature review)]Yu G Samoilova, M V Matveeva, Ya L Yakimova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 5, 2018
[Markers for cognitive impairments and variability of glycaemia in patients with type 1 diabetes mellitus]Yu G Samoilova, M A Rotkank, N G Zhukova, et al.
Voprosy Pitaniia|July 11, 2023
[Patterns of eating habits and body composition in primary school children]D V Podchinenova, O V Tabakaeva, L M Ogorodova, et al.
Terapevticheskii Arkhiv|May 11, 2023
[Genetic aspects of type 1 glucagon peptide agonists clinical efficacy: A review]E L Golovina, I R Grishkevich, O E Vaizova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 24, 2022
[Cerebral perfusion and tractography in obese children]Yu G Samoilova, M V Matveeva, O A Oleinik, et al.
Biomeditsinskaia Khimiia|September 14, 2023
Alpha-2 macroglobulin activity in SARS-CoV-2 induced infection and in the post-COVID-19 periodO E Akbasheva, D K Mitrofanova, L V Spirina, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 22, 2024
[Sarcopenia as a non-motor symptom of Parkinson's disease]N G Zhukova, M V Matveeva, P E Kazantseva, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|August 4, 2011
[Pharmacological effects of remaxol on endotoxicosis of peritonitis genesis]A P Vlasov, O V Loginova, V V Vasil'ev, et al.
Terapevticheskii Arkhiv|December 30, 2023
[Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review]E L Golovina, O E Vaizova, M V Meleshko, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 27, 2020
[Brain tractography in type 1 and 2 diabetes and cognitive impairment]Y G Samoilova, M V Matveeva, O S Tonkikh, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Voprosy Kurortologii, Fizioterapii, I Lechebnoi Fizicheskoi Kultury|June 27, 2024
[Physical rehabilitation in sarcopenia: modern approaches. (A literature review)]Yu G Samoilova, M V Matveeva, Ya L Yakimova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|June 5, 2018
[Markers for cognitive impairments and variability of glycaemia in patients with type 1 diabetes mellitus]Yu G Samoilova, M A Rotkank, N G Zhukova, et al.
Voprosy Pitaniia|July 11, 2023
[Patterns of eating habits and body composition in primary school children]D V Podchinenova, O V Tabakaeva, L M Ogorodova, et al.
Terapevticheskii Arkhiv|May 11, 2023
[Genetic aspects of type 1 glucagon peptide agonists clinical efficacy: A review]E L Golovina, I R Grishkevich, O E Vaizova, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 24, 2022
[Cerebral perfusion and tractography in obese children]Yu G Samoilova, M V Matveeva, O A Oleinik, et al.
Biomeditsinskaia Khimiia|September 14, 2023
Alpha-2 macroglobulin activity in SARS-CoV-2 induced infection and in the post-COVID-19 periodO E Akbasheva, D K Mitrofanova, L V Spirina, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 22, 2024
[Sarcopenia as a non-motor symptom of Parkinson's disease]N G Zhukova, M V Matveeva, P E Kazantseva, et al.
Eksperimental'Naia I Klinicheskaia Farmakologiia|August 4, 2011
[Pharmacological effects of remaxol on endotoxicosis of peritonitis genesis]A P Vlasov, O V Loginova, V V Vasil'ev, et al.
Terapevticheskii Arkhiv|December 30, 2023
[Clinical effectiveness and pharmacokinetics of gliflozin from the point of view of individual genetic characteristics: A review]E L Golovina, O E Vaizova, M V Meleshko, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|November 27, 2020
[Brain tractography in type 1 and 2 diabetes and cognitive impairment]Y G Samoilova, M V Matveeva, O S Tonkikh, et al.
Pageof 3